Changzhou Ruiming Pharmaceuticals Co., Ltd., located at No. 1558 Longjiang (North) Road, Changzhou, Jiangsu Province, is a forefront in pharmaceutical innovation. We are primarily focused on the production, research, development, and marketing of Active Pharmaceutical Ingredients (APIs) and intermediates. Our products are designed to combat cardiovascular, cerebrovascular, and urinary system diseases. Our company is the largest manufacturer of Amlodipine Besylate, a key API for cardiovascular and cerebrovascular diseases, in China. We adhere to international quality standards, having been certified by CGMP, FDA, EMA, and PMDA. We are looking forward to cooperate within API and formulations.
more >
Year of Establishment:
2003
Total Assets(USD):
choose not to disclose
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Trading Company
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Asia,Africa
Other Competitive Advantages:
Patents and Copyrights: